Single Dose Preemptive Paracetamol or Ibuprofen Before Septrorhinoplasty on Intra- and Postoperative Opioid Consumption.

ConditionAnalgesia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSamsun University

About this trial

Reducing intra- and postoperative pain or using less opioids is an essential strategy in today's operations. One emerging and widely used method in this context is the use of preemptive analgesic medication. Paracetamol and ibuprofen used preemptively have been shown to reduce postoperative opioid use and pain scores. There are also studies showing that preemptive analgesia with different analgesic medications reduces opioid consumption and postoperative pain. Our study will evaluate both the intraoperative and postoperative effectiveness of paracetamol and ibupurofen with preemptive analgesia, considering total opioid use. It will also investigate drug side effects and their advantages using a 15-question compilation quality scale, validated in Turkish.

Eligibility criteria

Qualifiers

Septorhinoplasty surgery

ASA1-2 patients

Men and women aged 18-65

Informed consent and acceptance to participate in the study

Disqualifiers

ASA 3-4 and under 18 years of age

Patients with serious renal, hepatological, cardiovascular, or pulmonary system diseases

Allergy to paracetamol or ibuprofen

Patients with bleeding diathesis, platelet dysfunction, GI disease, peptic ulcers, pregnancy, planning pregnancy, and breastfeeding mothers

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

54 Participants
are grouped into 3 trial groups

Sponsors and collaborators